ALLR Reports Earnings Tomorrow: What to Expect
Allarity Therapeutics reports Q1 2026 earnings May 9th with analysts expecting a $0.22 EPS loss. Focus on clinical progress, cash runway, and DRP platform updates.
Allarity Therapeutics reports Q1 2026 earnings May 9th with analysts expecting a $0.22 EPS loss. Focus on clinical progress, cash runway, and DRP platform updates.
Intensity Therapeutics Inc (INTS) reported second-quarter 2026 earnings that beat analyst expectations, posting a loss of $0.96 per share compared…
Turning Point Brands Inc (TPB) delivered a solid earnings beat for Q2 2026, reporting adjusted earnings per share of $0.76…
GCI Liberty Inc (GLIBA) delivered disappointing second-quarter 2026 results, reporting earnings per share of $0.45 versus analyst expectations of $1.25,…
MarketWise Inc (MKTW) reported a significant earnings miss for Q2 2026, posting a loss of $0.23 per share against analyst…
Ubiquiti Inc. reports earnings May 8, 2026, with analysts expecting $4.42 EPS on $840M revenue. Key focus on networking demand…
Hawaiian Electric Industries reports Q1 2026 earnings May 8 with $0.29 EPS estimate. Investors focus on wildfire liability updates and…
AngloGold Ashanti reports Q1 2026 earnings May 8 with EPS estimate of $2.32 and revenue of $3.42B. Key focus on…
TIC Solutions Inc (TIC) reported second-quarter 2026 earnings that exceeded analyst expectations, posting a loss of $0.07 per share versus…
Solstice Advanced Materials Inc (SOLS) reported second-quarter 2026 earnings that met Wall Street expectations on earnings per share while falling…